During the past decade, Air Forces Military Hospital of Athens conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Air Forces Military Hospital of Athens" #1 sponsor was "Hellenic Oncology Research Group" with 53 trials, followed by "251 Hellenic Air Force & VA General Hospital" with 2 trials sponsored, "Amgen" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Vaxon Biotech" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Air Forces Military Hospital of Athens" #1 collaborator was "University Hospital of Crete" with 34 trials as a collaborator, "Janssen Research & Development, LLC" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "424 General Military Hospital" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Air Forces Military Hospital of Athens" are "Breast Cancer" (17 trials), "Non Small Cell Lung Cancer" (13 trials), "Gastric Cancer" (4 trials), "Non-small-cell Lung Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Air Forces Military Hospital of Athens" in a lesser frequency.

Most popular intervention types in "Air Forces Military Hospital of Athens" are "Drug" (64 trials), "Device" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (20 trials), "Bevacizumab" (14 trials), "Gemcitabine" (11 trials), "Carboplatin" (9 trials) and "Epirubicin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Air Forces Military Hospital of Athens" are 53 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Air Forces Military Hospital of Athens". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Air Forces Military Hospital of Athens, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Air Forces Military Hospital of Athens, 8 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".